Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: A transcranial magnetic stimulation study

Experimental Brain Research

Volumn 163, Issue 1, 2005, Pages 128-131

  Nardone, Raffaele ^a   Florio, Igor ^a   Lochner, Piergiorgio ^a   Tezzon, Frediano ^a  

^a FRANZ TAPPEINER HOSPITAL   (Italy)

Author keywords

Acetylcholine; Afferent inhibition; Muscarinic receptors; Parkinson's disease; Progressive supranuclear palsy; Transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; EXCITABILITY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; TRANSCRANIAL MAGNETIC STIMULATION;

ACETYLCHOLINE; AGED; AGED, 80 AND OVER; CHOLINERGIC FIBERS; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; HUMANS; MIDDLE AGED; MOTOR CORTEX; NEURAL INHIBITION; NEURONS, AFFERENT; PARKINSON DISEASE; REACTION TIME; RECEPTORS, MUSCARINIC; SUPRANUCLEAR PALSY, PROGRESSIVE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 20944437395     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-005-2228-7     Document Type: Article

References (24)

1. Albert ML, Feldman RG, Willis AL (1974) The subcortical dementia of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37:121-130
2. APA (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised. American Psychiatric Association, Washington DC
3. Asahina M, Shinotoh H, Hirayama K, Suhara T, Shishido F, Inoue O, Tateno Y (1995) Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET. Acta Neurol Scand 91(6):437-43
4. Asahina M, Suhara T, Shinotoh H, Inoue O, Suzuki K, Hattori T (1998) Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry 65:155-163
5. Brown RG, Marsden CD (1988) Subcortical dementia: the neurophysiological evidence. Neuroscience 25:363-387
6. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM (1995) Progressive supranuclear palsy: neuropathologically based diagniostic clinical criteria. J Neurol Neurosurg Psychiatry 58:167-173
7. Di Lazzaro V, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 523:503-513
8. Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P, Saturno E, Pilato P, Fasullo C, Rothwell JC (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 13:392-397
9. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Bentivoglio AR, Tonali P (2004) Normal or enhanced short latency afferent inhibition in Parkinson's disease? Brain 127(Pt 4):E8
10. Flynn DD, Weinstein DA, Mash DC (1991) Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 29:256-262
11. Flynn DD, Ferrari-DiLeo G, Mash DC, Levey AJ (1995) Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J Neurochem 64:1888-1891
12. Lange KW, Wells FR, Jenner P, Marsden CD (1993) Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease. J Neurochem 60:197-203
13. Pillon B, Dubois B, L'Hermitte F, Agid Y (1986) Heterogeneicity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease and Alzheimer's disease. Neurology 36:1179-1185
14. Rogers JD, Brogan D, Mirra SS (1985) The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol 17:163-170
15. Ruberg M, Ploska A, Javoy-Agid F et al (1982) Muscarinic binding and choline acetyltransferase activity in Parkinson subjects with reference to dementia. Brain Res 232:129-139
16. Ruberg M, Javoy-Agid F, Hirsch E, Scatton B, Lheureux R, Hauw JJ, Duyckaerts C, Gray F, Morel-Maroger A, Rascol A et al (1985) Dopaminergic and cholinergic lesions in progressive supranulear palsy. Ann Neurol 18:523-529
17. Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003) Short and long latency afferent inhibition in Parkinson's disease. Brain 126:1883-84
18. Sirvio J, Rinne JO, Valjakka A, Rinne UK, Riekkinen PJ, Paljarvi L (1989) Different form of brain acetylcholinesterase and muscarinic binding in Parkinson's disease. J Neurol Sci 90:23-32
19. Taylor AE, Saint-Cyr JA, Lang AE (1986) Frontal lobe dysfunction in Parkinson's disease. Brain 109:845-883
20. Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523:503-513
21. Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E et al (eds) Advances in neurology, vol. 53. Parkinson's disease: anatomy, pathology, and therapy. Raven, New York, pp 245-249
22. Weinberger DR, Gibson R, Coppola R, Jones DW, Molchan S, Sunderland T, Berman KF, Reba RC (1991) The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia: a controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol 48:169-176
23. Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ (1988) Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch Neurol 45:722-724
24. Zweig RM, Whitehause PJ, Casanova MF, Walker LC, Jankel WR, Price DL (1987) Loss of peduncolopontine neurons in progressive supranuclear palsy. Ann Neurol 22:18-25